|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55.47 USD | +1.08% |
|
-1.33% | -6.66% |
| 07/04 | BioMarin Pharmaceutical Secures European Regulatory Approval for Amicus Therapeutics Acquisition | MT |
| 07/04 | EU Commission OKs BioMarin's Sole Acquisition of Amicus Therapeutics | MT |
| Capitalization | 1.07TCr 904.13Cr 832.8Cr 786.21Cr 1.47TCr 99TCr 1.49TCr 9.79TCr 3.83TCr 48TCr 4TCr 3.92TCr 1,69400Cr | P/E ratio 2026 * |
12.9x | P/E ratio 2027 * | 9.48x |
|---|---|---|---|---|---|
| Enterprise value | 1.18TCr 998.26Cr 919.5Cr 868.06Cr 1.62TCr 1,09700Cr 1.65TCr 11TCr 4.23TCr 53TCr 4.42TCr 4.33TCr 1,87100Cr | EV / Sales 2026 * |
3.07x | EV / Sales 2027 * | 2.76x |
| Free-Float |
99.12% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: BioMarin Pharmaceutical Inc.
| 1 day | +1.08% | ||
| 1 week | -1.33% | ||
| Current month | -1.81% | ||
| 1 month | -5.20% | ||
| 3 months | -1.09% | ||
| 6 months | +5.72% | ||
| Current year | -6.66% |
| 1 week | 53.88 |  | 57.09 |
| 1 month | 53.36 | | 58.8 |
| Current year | 53.36 | | 66.28 |
| 1 year | 50.76 | | 66.28 |
| 3 years | 50.76 | | 100.38 |
| 5 years | 50.76 | | 117.77 |
| 10 years | 50.76 | | 131.94 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alexander Hardy
CEO | Chief Executive Officer | 57 | 01/12/2023 |
Brian Mueller
DFI | Director of Finance/CFO | 52 | 29/01/2020 |
Gregory Friberg
CTO | Chief Tech/Sci/R&D Officer | 52 | 30/09/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Randy Meier
CHM | Chairman | 66 | 01/12/2023 |
Willard Dere
BRD | Director/Board Member | 72 | 18/07/2016 |
Robert Hombach
BRD | Director/Board Member | 60 | 29/09/2017 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -.--% | 3.45% | 1 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.08% | -1.33% | -7.04% | -43.98% | 1.07TCr | |
| +1.21% | -0.63% | +32.30% | -8.90% | 7.75TCr | |
| -0.96% | +0.07% | +88.07% | +205.24% | 6.08TCr | |
| -0.90% | +53.60% | +53.60% | +53.60% | 4.84TCr | |
| +0.98% | -1.93% | -42.88% | -53.81% | 4.73TCr | |
| +1.47% | +1.91% | +50.06% | -37.89% | 2.63TCr | |
| +4.26% | +5.45% | +97.16% | -66.37% | 2.1TCr | |
| +2.24% | +4.27% | +64.96% | +31.13% | 1.94TCr | |
| +0.22% | +1.33% | +54.73% | +51.99% | 1.55TCr | |
| +0.08% | +8.34% | +123.62% | +428.70% | 1.51TCr | |
| Average | +0.62% | +1.56% | +51.46% | +55.97% | 3.42TCr | |
| Weighted average by Cap. | +0.44% | +0.63% | +45.85% | +49.33% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 383.34Cr 324.88Cr 299.25Cr 282.51Cr 527.49Cr 36TCr 537.04Cr 3.52TCr 1.38TCr 17TCr 1.44TCr 1.41TCr 61TCr | 448.24Cr 379.89Cr 349.92Cr 330.34Cr 616.79Cr 42TCr 627.96Cr 4.11TCr 1.61TCr 20TCr 1.68TCr 1.65TCr 71TCr |
| Net income | 46Cr 39Cr 36Cr 34Cr 63Cr 4.27TCr 64Cr 420.84Cr 164.69Cr 2.05TCr 172.03Cr 168.39Cr 7.28TCr | 116.6Cr 99Cr 91Cr 86Cr 160.44Cr 11TCr 163.35Cr 1.07TCr 418.87Cr 5.21TCr 437.53Cr 428.29Cr 19TCr |
| Net Debt | 111.07Cr 94Cr 87Cr 82Cr 152.83Cr 10TCr 155.6Cr 1.02TCr 399Cr 4.97TCr 416.77Cr 407.97Cr 18TCr | 169.5Cr 143.65Cr 132.32Cr 124.92Cr 233.24Cr 16TCr 237.46Cr 1.56TCr 608.92Cr 7.58TCr 636.04Cr 622.61Cr 27TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/26/14 | 55.47 $ | +1.08% | 15,96,905 |
| 13/26/13 | 54.88 $ | +0.64% | 14,42,266 |
| 10/26/10 | 54.53 $ | -3.14% | 15,41,036 |
| 09/26/09 | 56.30 $ | -1.57% | 10,48,527 |
| 08/26/08 | 57.20 $ | +1.74% | 15,61,195 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BMRN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition